CPT, in rat liver mitochondria is inhibited by low concentrations of malonyl-CoA (McGarry et al., 1978) . It is suggested that this effect offer a mechanism by which rates of hepatic fatty acid oxidation (and hence ketogenesis) may be inversely related to rates of fatty acid synthesis (McGarry & Foster, 1980 ). More recently it was shown that CPT1 activity in mitochondria from varous other rat tissues can also be inhibited by low concentrations of malonyl-CoA (Saggerson & Carpenter, 198 lb). This effect was seen with CPT, from lipogenic tissues such as white adipocytes and lactating mammary gland and also in oxidative tissues, e.g. heart and skeletal muscle. Surprisingly, CPT, from these muscle tissues was approx. 10-15 times more sensitive to malonyl-CoA than was CPT, from liver.
The malonyl-CoA content of extrahepatic tissues is unknown at present, and may be extremely difficult to quantify. Thermogenesis in brown adipose tissue is accompanied by a high rate of fatty acid oxidation; for review see Nicholls (1979) . Measurements in vivo in the cold-adapted rat or in animals maintained at normal temperatures suggest that brown adipose tissue may also be extremely active in fatty acid synthesis (McCormack & Denton, 1977; Trayhurn, 1979; Agius & Williamson, 1980 (Saggerson & Carpenter, 1981a; Saggerson, 1982) .
The assays were linear with time and amounts of mitochondria. Zero-time blanks were measured and subtracted. Citrate synthase (EC 4.1.3.7) was assayed as described by Saggerson & Carpenter (198 la) .
Results and discussion
In other studies (Saggerson & Carpenter, 1981c; Saggerson, 1982) it has been demonstrated that, under the assay conditions used here, the relationship between heart or liver CPT, activity and [palmitoyl-CoA] is sigmoidal. Malonyl-CoA increases this apparent sigmoidicity, but does not appear to alter the maximum velocity. In the absence of malonyl-CoA, the kinetics with palmitoyl-CoA are more sigmoidal with heart CPT1 than with the liver enzyme (Saggerson & Carpenter, 1982) . Fig. 1 shows that, like heart CPT,, brown-adipose-tissue CPT1 activity showed a pronounced sigmoidal dependence on [palmitoyl-CoA] even in the absence of malonyl-CoA. Low concentrations of malonylCoA considerably inhibited the activity at low [palmitoyl-CoA] and increased the apparent sigmoidicity. This experiment was performed with mitochondria from rats maintained at normal temperature. Similar sigmoidicity in this curve was seen with CPT1 in mitochondria from cold-adapted rats. This treatment slightly decreased the CPT, activity per mg of protein (see also the legend to Fig.  2 ), but did not alter the concentration of palmitoylCoA giving half-maximal activity (38,uM) under these assay conditions. In the absence of malonylCoA Hill coefficients were 3.2 and 3.0 in the normal and cold-adapted states respectively. The activity per mg of protein of brown-adipose-tissue CPT in the absence of malonyl-CoA was comparable with that found under these assay conditions in other oxidative tissues, such as heart or skeletal muscle (Saggerson & Carpenter, 1981b , 1982 and higher than that found in liver, kidney, white adipocytes or mammary gland (Saggerson & Carpenter, 1981b Fig. 2 ) and by the observation that measurable citrate synthase activity increased 9.4-fold, from 142 to 1342nmol/min per mg of protein, on sonication. This citrate synthase activity is incidentally twice that found in mitochondria from rat mammary gland, skeletal muscle or heart (Saggerson & Carpenter, 1981b) and is matched only by the very high activity found in mitochondria from white adipocytes (Harper & Saggerson, 1975) or brain (Land et al., 1977) . states. Surprisingly, cold-adaptation for 3 weeks resulted in no change in this effect. The sensitivity of brown-adipose-tissue CPT, to malonyl-CoA was similar to that found with the enzyme from heart or skeletal muscle, but was approx. 50 times the sensitivity of the liver enzyme (see Fig. 1 of Saggerson & Carpenter, 1981b) . In both conditions approx. 20% of the measured brown-adipose-tissue CPT was insensitive to malonyl-CoA even at the highest concentrations tested. It is possible that a proportion of the mitochondria were damaged, thereby allowing access of the assay substrates to the CPT2 activity, which, in liver mitochondria, is reported to be insensitive to malonyl-CoA (McGarry et al., 1978) . However, the 20% proportion of the CPT activity that was malonyl-CoAinsensitive was most reproducibly and consistently observed in each mitochondrial preparation. It is unlikely that such a constant proportion of the mitochondria could be damaged from preparation to preparation. As indicated above, interscapular brown adipose tissue from cold-adapted rats appears to have a high rate of lipogenesis in vivo as measured by the incorporation of 3H from injected 3H20 into fatty acids in the tissue. It is of course possible that a proportion of this labelled fatty acid was derived from lipogenesis in other tissues, e.g. liver. However, the contention that brown adipose tissue is potentially active in lipogenesis is supported by the finding that the tissue has extremely high activities of pyruvate dehydrogenase and acetyl-CoA carboxylase (McCormack & Denton, 1977) . Clearly there is a conundrum here. Malonyl-CoA must be present in brown-fat cells in order to sustain the observed high rates of lipogenesis. How can this be compatible with a simultaneous high rate of fl-oxidation?
Measurements of the tissue content of malonylCoA will be necessary to establish the extent to which CPT1 might be inhibited in brown adipose tissue and to establish whether the content of this metabolite changes in different states. The presence of malonyl-CoA in the tissue, even if invariant, could bring about a highly sigmoidal relationship between CPT1 activity and the content of acyl-CoA substrates, hence rendering the rate of acyl-group entry into fl-oxidation highly sensitive to small changes in the amounts of these substrates. Alternatively, or additionally, other metabolites, as yet unrecognized, may also play a role in the regulation of CPT1, perhaps to oppose the effect of malonyl-CoA.
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